Literature DB >> 16029052

Editorial: targeted drug delivery for cancer.

K K Jain.   

Abstract

Cancer drug delivery is no longer simply wrapping the drug in new formulations for different routes of delivery. Knowledge and experience from other technologies such as nanotechnology, advanced polymer chemistry, and electronic engineering, are being brought together in developing novel methods of drug delivery. Advances in our knowledge of molecular biology of cancer and pathways involved in malignant transformation of cells are revolutionizing the approach to cancer treatment with a focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also aim to prevent damage to the normal tissues and overcome drug resistance. Innovative methods of cancer treatment require new concepts of drug delivery in cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029052     DOI: 10.1177/153303460500400401

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  4 in total

1.  Magnetically mediated release of ciprofloxacin from polyvinyl alcohol based superparamagnetic nanocomposites.

Authors:  A K Bajpai; Rashmi Gupta
Journal:  J Mater Sci Mater Med       Date:  2010-12-29       Impact factor: 3.896

Review 2.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

3.  Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

Authors:  Moutushy Mitra; Ranjita Misra; Anju Harilal; Sanjeeb K Sahoo; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2011-10-19       Impact factor: 2.367

4.  Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).

Authors:  Yuangang Zu; Yu Zhang; Xiuhua Zhao; Qi Zhang; Yang Liu; Ru Jiang
Journal:  Int J Nanomedicine       Date:  2009-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.